Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Targeting NF-kappaB in hematologic malignancies.

T Braun1, G Carvalho, C Fabre

  • 1Centre National de la Recherche Scientifique, UMR8125, Institut Gustave Roussy, 39 rue Camille-Desmoulins, F-94805 Villejuif, France.

Cell Death and Differentiation
|February 25, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Factors for pain in office-based voice implant replacement. A multicenter prospective GETTEC study.

European annals of otorhinolaryngology, head and neck diseases·2025
Same author

Herbal medicines and blood pressure control among hypertensive individuals across two of trinidad's regional health facilities.

BMC complementary medicine and therapies·2025
Same author

The most commonly used free flap for reconstruction in ENT oncology.

European annals of otorhinolaryngology, head and neck diseases·2025
Same author

Asbestos and head-and-neck cancer: An important association for patient monitoring and compensation.

European annals of otorhinolaryngology, head and neck diseases·2025
Same author

Evaluation of the effectiveness of bone obliteration in cholesteatoma surgery.

European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery·2025
Same author

Cervical resection of Zenker's diverticulum.

European annals of otorhinolaryngology, head and neck diseases·2025

Nuclear factor kappa B (NF-kappaB) plays a key role in cancer development and drug resistance. Inhibiting NF-kappaB offers a promising therapeutic strategy for hematological malignancies.

Area of Science:

  • Molecular Biology
  • Oncology
  • Immunology

Background:

  • Nuclear factor kappa B (NF-kappaB) is a transcription factor regulating genes involved in cell survival, proliferation, inflammation, and metastasis.
  • Aberrant NF-kappaB activation is implicated in the pathogenesis of lymphoid and myeloid malignancies, including myelodysplastic syndromes.

Purpose of the Study:

  • To explore the role of NF-kappaB in oncogenesis and hematological malignancies.
  • To evaluate the therapeutic potential of targeting NF-kappaB activation in cancer treatment.

Main Methods:

  • Review of existing literature on NF-kappaB function in cancer.
  • Investigation of small molecule inhibitors targeting NF-kappaB pathway components (e.g., IKK, proteasome, NF-kappaB subunits).

Related Experiment Videos

Main Results:

  • NF-kappaB regulates critical processes in cancer, including apoptosis suppression and cell survival.
  • Cytotoxic chemotherapy can paradoxically activate NF-kappaB, leading to drug resistance.
  • Inhibitors of NF-kappaB are under investigation for therapeutic applications.

Conclusions:

  • Targeting intrinsic NF-kappaB activation presents a potential therapeutic avenue for hematological malignancies.
  • NF-kappaB inhibitors may be effective as standalone treatments or in combination with chemotherapy to overcome drug resistance.